Vimarsana
Biggest News Aggregation in the World

Including Stroke News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Including Stroke. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Including Stroke Today - Breaking & Trending Today

Alkermes Presents Clinical and Real-World Data at 36th Annual Psych Congress - Vimarsana News

Alkermes Presents Clinical and Real-World Data at 36th Annual Psych Congress

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced the presentation of multiple posters highlighting real-world and clinical data at the 36th Annual...

Alkermes plc: Alkermes Highlights Data From Psychiatry Portfolio at Spring 2023 Scientific Conferences - Vimarsana News

Alkermes plc: Alkermes Highlights Data From Psychiatry Portfolio at Spring 2023 Scientific Conferences

? Clinical and Patient Experience Research Delivers Insights into Treatment for People Living with Schizophrenia or Bipolar I Disorder ? DUBLIN, May 16, 2023 /PRNewswire/ -- Alkermes

Otsuka and Lundbeck Issue Statement on U.S. Food and Drug Administration (FDA) Advisory Committee Meeting on REXULTI® (brexpiprazole) for the Treatment of Agitation Associated with Alzheimer's Dementia | Illinois - Vimarsana News

Otsuka and Lundbeck Issue Statement on U.S. Food and Drug Administration (FDA) Advisory Committee Meeting on REXULTI® (brexpiprazole) for the Treatment of Agitation Associated with Alzheimer's Dementia | Illinois

PRINCETON, N.J. & DEERFIELD, Ill.--(BUSINESS WIRE)--Apr 16, 2023--

Source: wsiltv.com
Otsuka and Lundbeck Issue Statement on U.S. Food and Drug Administration (FDA) Advisory Committee Me - Vimarsana News

Otsuka and Lundbeck Issue Statement on U.S. Food and Drug Administration (FDA) Advisory Committee Me

The Prescription Drug User Fee Act (PDUFA) target action date is May 10, 2023PRINCETON, N.J. & DEERFIELD, Ill.--(BUSINESS WIRE)--Otsuka Pharmaceutical Development & Commercialization, Inc., (Otsuka) and Lundbeck Pharmaceuticals LLC (Lundbeck) announce the Joint Meeting of the Psychopharmacologic Drugs Advisory C...

Otsuka Pharmaceutical & Lundbeck Present Positive Data From Multiple Phase 3 Studies Showing Brexpip - Vimarsana News

Otsuka Pharmaceutical & Lundbeck Present Positive Data From Multiple Phase 3 Studies Showing Brexpip

Researchers highlight efficacy and safety data across three Phase 3 studies of brexpiprazole for agitation in Alzheimer’s dementiaAgitation is a highly prevalent clinical manifestation in Alzheimer’s dementia and one of the most complex and stressful aspects of care in patients affected by the disease. It is associa...